The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase ib and phase II studies of pembrolizumab (P) with bevacizumab (B) for the treatment of metastatic renal cell carcinoma (RCC): BTCRC-GU14-003.
 
Arkadiusz Z. Dudek
Employment - Adhaere Pharmaceuticals
Leadership - IGF Oncology; Martell diagnostic
Stock and Other Ownership Interests - Biothera; IGF Oncology; Vanquish Oncology
Honoraria - Biothera; IGF Oncology; Medtronic; Vanquish Oncology
Consulting or Advisory Role - Biothera; TTC Oncology; Vanquish Oncology
 
Li C Liu
No Relationships to Disclose
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; Eisai; Roche
Speakers' Bureau - AstraZeneca
Research Funding - Acerta Pharma (Inst); ARIAD (Inst); AstraZeneca (Inst); Bayer (Inst); BIND Biosciences (Inst); BIND Biosciences (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); United Biosource Corporation (Inst)
 
Mark Stein
No Relationships to Disclose
 
Shilpa Gupta
Consulting or Advisory Role - Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Pfizer
Research Funding - Astellas Medivation (Inst); Innocrin Pharma (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst)
 
Costantine Albany
No Relationships to Disclose
 
Monika Joshi
Research Funding - AstraZeneca (Inst)
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Castle Biosciences; Eisai; Exelixis; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Newlink Genetics
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - Sanofi; Sanofi
Research Funding - Agensys (Inst); Medivation (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
James K. Schwarz
No Relationships to Disclose
 
Anas Al-Janadi
Honoraria - Alexion Pharmaceuticals; Celgene; Genentech/Abbvie; Genentech/Roche; Gilead Sciences; Incyte; Sandoz-Novartis; Seagen; Takeda
Consulting or Advisory Role - Alexion Pharmaceuticals; Gilead Sciences; Sandoz-Novartis; Seagen; Takeda
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Genentech/Abbvie; Genentech/Roche
Research Funding - Alexion Pharmaceuticals (Inst); Celgene (Inst); Incyte (Inst); MEI Pharma (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Celgene; Genentech/Abbvie; Genentech/Roche; Gilead Sciences; Incyte; Seagen; Takeda